Corient Private Wealth LP Purchases New Shares in Astera Labs, Inc. $ALAB

Corient Private Wealth LP purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 21,270 shares of the company's stock, valued at approximately $10,192,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Atreides Management LP acquired a new position in Astera Labs in the 2nd quarter worth $587,736,000. Ausdal Financial Partners Inc. acquired a new stake in shares of Astera Labs during the second quarter valued at about $807,000. Avenir Tech Ltd acquired a new stake in shares of Astera Labs during the second quarter valued at about $3,794,000. Bank of America Corp DE purchased a new stake in shares of Astera Labs during the second quarter worth about $1,061,791,000. Finally, Light Street Capital Management LLC purchased a new stake in shares of Astera Labs during the second quarter worth about $60,740,000. Institutional investors and hedge funds own 60.47% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. Morgan Stanley increased their price target on Astera Labs to $335.00 and gave the company an "overweight" rating in a report on Monday, August 3rd. JPMorgan Chase & Co. lifted their price objective on Astera Labs from $205.00 to $280.00 and gave the stock an "overweight" rating in a report on Wednesday, May 6th. Susquehanna upped their target price on Astera Labs from $230.00 to $275.00 and gave the company a "neutral" rating in a research report on Friday, July 31st. Needham & Company LLC increased their target price on Astera Labs from $260.00 to $425.00 and gave the company a "buy" rating in a research note on Wednesday, August 5th. Finally, Bank of America raised their price target on shares of Astera Labs from $240.00 to $450.00 and gave the stock a "neutral" rating in a research report on Tuesday, June 23rd. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $340.53.

Insiders Place Their Bets

In other news, COO Sanjay Gajendra sold 90,630 shares of the business's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 136,974 shares of the company's stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the sale, the director directly owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. This represents a 9.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 419,244 shares of company stock worth $163,135,169. Corporate insiders own 10.40% of the company's stock.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $289.47 on Friday. The company has a market capitalization of $50.22 billion, a price-to-earnings ratio of 143.30 and a beta of 3.84. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48. The stock has a 50-day simple moving average of $342.38 and a 200 day simple moving average of $249.65.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to analysts' expectations of $360.85 million. During the same quarter in the prior year, the firm posted $0.44 earnings per share. Astera Labs's revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source